SCHEMBL29520695

SCHEMBL29520695

CC(C)(C)C1=Nc2ccccc2C(=Cc2ccccc2)C(c2ccccc2)=N1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.43
KMT2A Q03164 7/20 0.43
MEN1 O00255 6/20 0.43
LMNA P02545 5/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 3/20 0.43
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
RECQL P46063 1/20 0.43
CCR6 P51684 1/20 0.43
MCL1 Q07820 1/20 0.43
GSK3B P49841 1/20 0.43
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
IDO1 P14902 1/20 0.40
THRB P10828 1/20 0.39
PLK1 P53350 1/20 0.36
PSMD14 O00487 1/20 0.36
GAA P10253 1/20 0.34
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29520487 0.86 IDO1 (0.41) MAPTKMT2AMEN1LMNAALDH1A1
SCHEMBL29520772 0.80 MAPT (0.47) MAPTKMT2AMEN1LMNAALDH1A1
SCHEMBL18481549 0.75 MAPT (0.46) MAPTKMT2AMEN1LMNAALDH1A1
SCHEMBL29520832 0.73 MAPT (0.42) MAPTKMT2AMEN1LMNAALDH1A1
SCHEMBL29520737 0.72 IDO1 (0.40) MAPTKMT2AMEN1LMNAALDH1A1
SCHEMBL29520723 0.71 IDO1 (0.39) MAPTKMT2AMEN1LMNAALDH1A1
SCHEMBL29520777 0.71 IDO1 (0.39) MAPTLMNAHTTNPSR1IDO1
SCHEMBL29520290 0.70 IDO1 (0.38) MAPTLMNAHTTNPSR1IDO1
SCHEMBL28698373 0.65 PLK1 (0.41) MAPTKMT2AMEN1LMNAALDH1A1
SCHEMBL27845629 0.65 PLK1 (0.41) MAPTKMT2AMEN1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112174901-B Synthesis method and anticancer activity of 1, 3-benzodiazepine compound 河南师范大学 2022-02-08 CN disclosed